Journals / Turkish Journal of Chemistry / 2018 / Cilt: 42 - Sayı: 4

Synthesis, molecular docking, and pharmacological evaluation of halobenzodithiophene derivatives against alpha-glucosidase, urease, and free radical production

Pages
1113–1123
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, compound 2,7-bis (butoxycarbonyl)-3,6-dichlorobenzo[1,2- b ;6,5- b ’] dithiophene (2) with two chlorine substitutions exhibited potent DPPH radical scavenging activity compared to other derivatives.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Benzodithiophenes are heterocyclic compounds that have various medicinal and industrial applications.
📊
Key Findings & Data:In the alpha-glucosidase inhibition assay, compound 2,2-bisbenzothiophne (1) exhibited potent activity with IC50 = 135 ± 0.51 µM, while its derivative 2,7-bis(butoxycarbonyl)-3,6-dichlorobenzo[1,2- b ;6,5- b ’]dithiophene (2) exhibited promising inhibition with IC50 = 263 ± 0.32 µM.
💡
Conclusion & Impact:Moreover, compound 2,7-bis (butoxycarbonyl)-3,6-dichlorobenzo[1,2- b ;6,5- b ’] dithiophene (2) with two chlorine substitutions exhibited potent DPPH radical scavenging activity compared to other derivatives.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Benzodithiophenes are heterocyclic compounds that have various medicinal and industrial applications. In the present study, halobenzodithiophene, the simplest benzofused thiophene, and its derivatives were synthesized and evaluated against alpha-glucosidase, urease, and free radical production. In the alpha-glucosidase inhibition assay, compound 2,2-bisbenzothiophne (1) exhibited potent activity with IC50 = 135 ± 0.51 µM, while its derivative 2,7-bis(butoxycarbonyl)-3,6-dichlorobenzo[1,2- b ;6,5- b ’]dithiophene (2) exhibited promising inhibition with IC50 = 263 ± 0.32 µM. In the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging assay, compound 2 exhibited promising activity with IC50 = 33 ± 0.42 µM, while compound 1 showed moderate inhibition in the urease inhibition assay. Molecular docking studies determined the possible interaction of benzodithiophene and alpha-glucosidase on the basis of binding energy and scoring function. Structure–activity relationship analysis revealed that compound 2,7-bis (butoxycarbonyl)-3,6-dichlorobenzo[1,2- b ;6,5- b ’] dithiophene (2) containing two chlorine substitutions exhibited more alpha-glucosidase inhibition (IC50 = 263 ± .0.32 µM) than other derivatives. Moreover, compound 2,7-bis (butoxycarbonyl)-3,6-dichlorobenzo[1,2- b ;6,5- b ’] dithiophene (2) with two chlorine substitutions exhibited potent DPPH radical scavenging activity compared to other derivatives.

🔖

Cite This Article

ABBAS, G., HASSAN, Z., AL-HARRASI, A., MUHAMAAD, S. A., AL-QURAINI, A. J., AL-MAANI, Z. K., AL-ADAWAI, A. M. (2022). Synthesis, molecular docking, and pharmacological evaluation of halobenzodithiophene derivatives against alpha-glucosidase, urease, and free radical production. Turkish Journal of Chemistry, Cilt: 42 - Sayı: 4, 1113–1123. https://ajindex.com/articles/601765

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. Copeland, R. A. Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists, Second Edition; Wiley: Hoboken, NJ, USA, 2013
  2. Chiasson, J. L. Endocr. Pract. 2006, 12, 25-30
  3. Van de Laar, F. A.; Lucassen, P. L.; Akkermans, R. P.; van de Lisdonk, E. H.; Rutten, G. E.; van Weel, C. Diabetes Care 2005, 28, 154-163
  4. Andrews, R. K.; Blakeley, R. L.; Zerner, B. In Advances in Inorganic Biochemistry, Vol. 6; Eichhorn, G. L.; Marzilli, L. G., Eds. Elsevier: New York, NY, USA, 1984
  5. Ghous, T.; Akhtar, K.; Choudhry, M. A. Biology and Medicine 2010, 2, 64-69
  6. Houimel, M.; Mach, J. P.; Corthésy-Theulaz, I.; Corthesy, B.; Fisch, I. Eur. J. Biochem. 1999, 262, 774-780
  7. Khan, I.; Ali, S.; Hameed, S.; Rama, N. H.; Hussain, M. T.; Wadood, A.; Uddin, R.; Ul-Haq, Z.; Khan, A.; Ali, S.; Choudhary M. I. Eur. J. Med. Chem. 2010, 45, 5200-5207
  8. Cadenas, E.; Davies, K. J. Free Radical Bio. Med. 2000, 29, 222-230
  9. Prior, R. L.; Wu, X.; Schaich, K. J. Agr. Food Chem. 2005, 53, 4290-4302
  10. Mabkhot, Y. N.; Barakat, A.; Al-Majid, A. M.; Alshahrani, S.; Yousuf, S.; Choudhary, M. I. Chem. Cent. J. 2013, 7, 112
  11. Nakano, M.; Niimi, K.; Miyazaki, E.; Osaka, I.; Takimiya, K. J. Org. Chem. 2012, 77, 8099-8111
  12. Kumagai, J.; Hirano, K.; Satoh, T.; Seki, S.; Miura, M. J. Phys. Chem-US. 2011, 115, 8446-8452
  13. Isloor, A. M.; Kalluraya, B.; Pai, K. S. Eur. J. Med. Chem. 2010, 45, 825-830
  14. Fakhr, I. M.; Radwan, M. A.; El-Batran, S.; El-Salam, O. M. A.; El-Shenawy, S. M. Eur J. Med. Chem. 2009, 44, 1718-1725
  15. Hassan, Z.; Al-Harrasi, A.; Rizvi, T.; Hussain, J.; Langer, P. Synthesis 2017, 49, 557-564
  16. Hassan, Z.; Reimann, S.; Wittler, K.; Ludwig, R.; Villinger, A.; Langer, P. Adv. Synth. Catal. 2012, 354, 731-739
  17. Hong, H.C.; Li, S. L.; Zhang, X. Q.; Ye, W. C.; Zhang, Q. W. Chin. Med-UK 2013, 8, 1-7
  18. Mosihuzzman, M.; Naheed, S.; Hareem, S.; Talib, S.; Abbas, G.; Khan, S. N.; Choudhary, M. I.; Sener, B. Tareen, R. B.; Israr, M. Life Sci. 2013, 92, 187-192
  19. Lee, S. K.; Mbwambo, Z. H.; Chung, H.; Luyengi, L.; Gamez, E. J.; Mehta, R. G. Comb. Chem. High T. Scr. 1998, 1, 35-46
  20. Serwar, M.; Akhtar, T.; Hameed, S.; Khan, K. M. ARKIVOC 2009, 7, 210-221.